198 related articles for article (PubMed ID: 35939511)
1. Genome-wide screening identified SEC61A1 as an essential factor for mycolactone-dependent apoptosis in human premonocytic THP-1 cells.
Kawashima A; Kiriya M; En J; Tanigawa K; Nakamura Y; Fujiwara Y; Luo Y; Maruyama K; Watanabe S; Goto M; Suzuki K
PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010672. PubMed ID: 35939511
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the SEC61 translocon by mycolactone induces a protective autophagic response controlled by EIF2S1-dependent translation that does not require ULK1 activity.
Hall BS; Dos Santos SJ; Hsieh LT; Manifava M; Ruf MT; Pluschke G; Ktistakis N; Simmonds RE
Autophagy; 2022 Apr; 18(4):841-859. PubMed ID: 34424124
[TBL] [Abstract][Full Text] [Related]
3. Inflammasome-triggered IL-18 controls skin inflammation in the progression of Buruli ulcer.
Suzuki T; Boonyaleka K; Okano T; Iida T; Yoshida M; Fukano H; Hoshino Y; Iwakura Y; Ablordey AS; Ashida H
PLoS Pathog; 2023 Nov; 19(11):e1011747. PubMed ID: 37910490
[TBL] [Abstract][Full Text] [Related]
4. Sec61 blockade by mycolactone: A central mechanism in Buruli ulcer disease.
Demangel C; High S
Biol Cell; 2018 Nov; 110(11):237-248. PubMed ID: 30055020
[TBL] [Abstract][Full Text] [Related]
5. The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer.
Hall BS; Hsieh LT; Sacre S; Simmonds RE
Front Immunol; 2021; 12():788146. PubMed ID: 35154073
[TBL] [Abstract][Full Text] [Related]
6. Aberrant stromal tissue factor localisation and mycolactone-driven vascular dysfunction, exacerbated by IL-1β, are linked to fibrin formation in Buruli ulcer lesions.
Hsieh LT; Dos Santos SJ; Hall BS; Ogbechi J; Loglo AD; Salguero FJ; Ruf MT; Pluschke G; Simmonds RE
PLoS Pathog; 2022 Jan; 18(1):e1010280. PubMed ID: 35100311
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insights into the inhibition of Sec61-dependent co- and post-translational translocation by mycolactone.
McKenna M; Simmonds RE; High S
J Cell Sci; 2016 Apr; 129(7):1404-15. PubMed ID: 26869228
[TBL] [Abstract][Full Text] [Related]
8. Immunity against Mycobacterium ulcerans: The subversive role of mycolactone.
Demangel C
Immunol Rev; 2021 May; 301(1):209-221. PubMed ID: 33607704
[TBL] [Abstract][Full Text] [Related]
9. Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease.
Sarfo FS; Phillips R; Wansbrough-Jones M; Simmonds RE
Cell Microbiol; 2016 Jan; 18(1):17-29. PubMed ID: 26572803
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional adaptation of
Robbe-Saule M; Foulon M; Poncin I; Esnault L; Varet H; Legendre R; Besnard A; Grzegorzewicz AE; Jackson M; Canaan S; Marsollier L; Marion E
Virulence; 2021 Dec; 12(1):1438-1451. PubMed ID: 34107844
[No Abstract] [Full Text] [Related]
11. Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer.
Tobias NJ; Seemann T; Pidot SJ; Porter JL; Marsollier L; Marion E; Letournel F; Zakir T; Azuolas J; Wallace JR; Hong H; Davies JK; Howden BP; Johnson PD; Jenkin GA; Stinear TP
PLoS Negl Trop Dis; 2009 Nov; 3(11):e553. PubMed ID: 19936295
[TBL] [Abstract][Full Text] [Related]
12. Mycolactone cytotoxicity in Schwann cells could explain nerve damage in Buruli ulcer.
En J; Kitamoto S; Kawashima A; Yonezawa S; Kishi Y; Ishii N; Goto M
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005834. PubMed ID: 28783752
[TBL] [Abstract][Full Text] [Related]
13. Induced Synthesis of Mycolactone Restores the Pathogenesis of
Strong E; Hart B; Wang J; Orozco MG; Lee S
Front Immunol; 2022; 13():750643. PubMed ID: 35401531
[No Abstract] [Full Text] [Related]
14. From Bacterial Toxin to Therapeutic Agent: The Unexpected Fate of Mycolactone.
Ricci D; Demangel C
Toxins (Basel); 2023 May; 15(6):. PubMed ID: 37368670
[TBL] [Abstract][Full Text] [Related]
15. The pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ER.
Hall BS; Hill K; McKenna M; Ogbechi J; High S; Willis AE; Simmonds RE
PLoS Pathog; 2014 Apr; 10(4):e1004061. PubMed ID: 24699819
[TBL] [Abstract][Full Text] [Related]
16. Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (buruli ulcer) in a murine study.
En J; Goto M; Nakanaga K; Higashi M; Ishii N; Saito H; Yonezawa S; Hamada H; Small PL
Infect Immun; 2008 May; 76(5):2002-7. PubMed ID: 18316387
[TBL] [Abstract][Full Text] [Related]
17. Molecular Docking and Dynamics Simulation Studies Predict Munc18b as a Target of Mycolactone: A Plausible Mechanism for Granule Exocytosis Impairment in Buruli Ulcer Pathogenesis.
Kwofie SK; Dankwa B; Enninful KS; Adobor C; Broni E; Ntiamoah A; Wilson MD
Toxins (Basel); 2019 Mar; 11(3):. PubMed ID: 30934618
[TBL] [Abstract][Full Text] [Related]
18. Detection of Mycolactone A/B in Mycobacterium ulcerans-Infected Human Tissue.
Sarfo FS; Phillips RO; Rangers B; Mahrous EA; Lee RE; Tarelli E; Asiedu KB; Small PL; Wansbrough-Jones MH
PLoS Negl Trop Dis; 2010 Jan; 4(1):e577. PubMed ID: 20052267
[TBL] [Abstract][Full Text] [Related]
19. Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans.
Warryn L; Dangy JP; Gersbach P; Gehringer M; Schäfer A; Ruf MT; Ruggli N; Altmann KH; Pluschke G
PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008357. PubMed ID: 32589646
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.
Adusumilli S; Mve-Obiang A; Sparer T; Meyers W; Hayman J; Small PL
Cell Microbiol; 2005 Sep; 7(9):1295-304. PubMed ID: 16098217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
